Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
CRISPR-Cas9
Tag: CRISPR-Cas9
Biotechnology
CRISPR Screen Reveals Control Knob for Regulatory T Cells
BioChannel
-
July 8, 2020
Biotechnology
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living...
BioChannel
-
July 1, 2020
Biotechnology
COVID-19 Mouse CRISPR Engineered to Recapitulate Human COVID-19
BioChannel
-
May 27, 2020
Biotechnology
Genome Editing Helps Cell Lines “Clean Up” Their Protein Production
BioChannel
-
May 5, 2020
Biotechnology
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
BioChannel
-
March 20, 2020
Biotechnology
CRISPR Base Editor Repairs Faulty Genes in Cystic Fibrosis Organoids
BioChannel
-
February 20, 2020
Biotechnology
“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types
BioChannel
-
January 23, 2020
Biotechnology
Leukemia’s Favorite Fix, Vitamin B6, Vulnerable to Pharmacological Blockade
BioChannel
-
January 13, 2020
Biotechnology
The Outlook for 2020 and Beyond
BioChannel
-
January 3, 2020
Biotechnology
NIH Director Backs Moratorium for Heritable Genome Editing
BioChannel
-
November 8, 2019
1
2
Page 1 of 2
Stay connected
50,943
Followers
Follow
14,700
Subscribers
Subscribe
Recent posts
Life in the Time of Coronavirus
BioChannel
-
July 10, 2020
Study pinpoints brain cells that trigger sugar cravings and consumption
BioChannel
-
July 10, 2020
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
BioChannel
-
July 10, 2020
Random article
Life in the Time of Coronavirus
Study pinpoints brain cells that trigger sugar cravings and consumption
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
VarmX bags €32m in Series B round – European Biotechnology News
Edit with Live CSS